FindTrial
Sign In

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00377546
Enrollment
Unknown
Registered
2006-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2008-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitrectomy

Keywords

Retinal Surgery

Brief summary

To compare the penetration of three different NSAIDs.

Interventions

DRUGNepafenac
DRUGKetorolac LS, Bromfenac

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Males or females scheduled to undergo Vitrectomy surgery * Likely to complete all study visits and able to provide informed consent * Visual potential of 20/25 or better

Exclusion criteria

* Known contraindications to any study medication or ingredients * Active ocular diseases or uncontrolled systemic disease * Active ocular allergies

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026